|
1
|
Fusco R, Petrillo A, Catalano O, Sansone
M, Granata V, Filice S, D'Aiuto M, Pankhurst Q and Douek M:
Procedures for location of non-palpable breast lesions: A
systematic review for the radiologist. Breast Cancer. 21:522–531.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gerlinger M, Rowan AJ, Horswell S, Larkin
J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A,
Tarpey P, et al: Intratumor heterogeneity and branched evolution
revealed by multiregion sequencing. N Engl J Med. 366:883–892.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bidard FC, Fehm T, Ignatiadis M, Smerage
JB, Alix-Panabières C, Janni W, Messina C, Paoletti C, Müller V,
Hayes DF, et al: Clinical application of circulating tumor cells in
breast cancer: Overview of the current interventional trials.
Cancer Metastasis Rev. 32:179–188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bettegowda C, Sausen M, Leary RJ, Kinde I,
Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al:
Detection of circulating tumor DNA in early-and late-stage human
malignancies. Sci Transl Med. 6:224ra242014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dawson SJ, Tsui DW, Murtaza M, Biggs H,
Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B,
et al: Analysis of circulating tumor DNA to monitor metastatic
breast cancer. N Engl J Med. 368:1199–1209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang L, Xiao H, Karlan S, Zhou H, Gross
J, Elashoff D, Akin D, Yan X, Chia D, Karlan B and Wong DT:
Discovery and preclinical validation of salivary transcriptomic and
proteomic biomarkers for the non-invasive detection of breast
cancer. PLoS One. 5:e155732010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burbelo PD, Bayat A, Lebovitz EE and
Iadarola MJ: New technologies for studying the complexity of oral
diseases. Oral Dis. 18:121–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gonçalves Lda R, Soares MR, Nogueira FC,
Garcia C, Camisasca DR, Domont G, Feitosa AC, Pereira Dde A,
Zingali RB and Alves G: Comparative proteomic analysis of whole
saliva from chronic periodontitis patients. J Proteomics.
73:1334–1341. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Delmonico L, Moreira Ados S, Franco MF,
Esteves EB, Scherrer L, Gallo CV, do Nascimento CM, Ornellas MH, de
Azevedo CM, Alves G, et al: CDKN2A (p14 (ARF)/p16 (INK4a)) and ATM
promoter methylation in patients with impalpable breast lesions.
Hum Pathol. 46:1540–1547. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abraham JE, Maranian MJ, Spiteri I,
Russell R, Ingle S, Luccarini C, Earl HM, Pharoah PP, Dunning AM
and Caldas C: Saliva samples are a viable alternativeto blood
samples as source of DNA for high throughput genotyping. BMC Med
Genomics. 5:192012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prieto DA, Johann DJ Jr, Wei BR, Ye X,
Chan KC, Nissley DV, Simpson RM, Citrin DE, Mackall CL, Linehan WM
and Blonder J: Mass spectrometry in cancer biomarker research: A
case for immunodepletion of abundant blood-derived proteins from
clinical tissue specimens. Biomark Med. 8:269–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Murray KK: Coupling matrix-assisted laser
desorption/ionization to liquid separations. Mass Spectrometry
Reviews. 16:(5th). Wiley Periodicals, Inc. (Hoboken, NJ). 283–289.
1997. View Article : Google Scholar
|
|
13
|
D'Orsi CJ, Sickles EA, Mendelson EB,
Morris EA, Creech WE, Butler PF, Wiegmann PG, Chatfield MB, Meyer
LW and Wilcox PA: ACR BI-RADS® Atlas, Breast Imaging
Reporting and Data System (4th). American College of Radiology.
Reston, VA: 2013.
|
|
14
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH
and van de Vijver MJ: WHO classification of tumours of the breast
(4th). IARC Press. Lyon: 2012.
|
|
15
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I. The value of histological
grade in breast cancer: experience from a large study with
long-term follow-up. Histopathology. 41:154–161. 2002.PubMed/NCBI
|
|
16
|
Smith PK, Krohn RI, Hermanson GT, Mallia
AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and
Klenk DC: Measurement of protein using bicinchoninic acid. Anal
Biochem. 150:76–85. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Delmonico L, Areias VR, Pinto RC, Matos
Cda S, Rosa MF, De Azevedo CM and Alves G: Protein identification
from dried nipple aspirate fluid on Guthrie cards using mass
spectrometry. Mol Med Rep. 12:159–164. 2015.PubMed/NCBI
|
|
18
|
Nesvizhskii AI, Keller A, Kolker E and
Aebersold R: A statistical model for identifying proteins by tandem
mass spectrometry. Anal Chem. 75:4646–4658. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sethi MK, Thaysen-Andersen M, Kim H, Park
CK, Baker MS, Packer NH, Paik YK, Hancock WS and Fanayan S:
Quantitative proteomic analysis of paired colorectal cancer and non
tumorigenic tissues reveals signature proteins and perturbed
pathways involved CRC progression and metastasis. J Proteomics.
126:54–67. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Wit M, Kant H, Piersma SR, Pham TV,
Mongera S, van Berkel MP, Boven E, Pontén F, Meijer GA, Jimenez CR
and Fijneman RJ: Colorectal cancer candidate biomarkers identified
by tissue secretome profiling. J Proteomics. 99:26–39. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mirzaei M, Soltani N, Sarhadi E, George
IS, Neilson KA, Pascovici D, Shahbazian S, Haynes PA, Atwell BJ and
Salekdeh GH: Manipulating root water supply elicts major shifts in
the shoot proteome. J Proteome Res. 13:517–526. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smit MA, Maddalo G, Greig K, Raaijmakers
LM, Possik PA, van Breukelen B, Cappadona S, Heck AJ, Altelaar AF
and Peeper DS: ROCK1 is a potencial combinatorial drug target for
BRAF mutant melanoma. Mol Syst Biol. 10:7722014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal
A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O,
Campbell MJ, et al: The PANTHER database of protein families,
subfamilies, functions and pathways. Nucleic Acids Res.
33:D284–D288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carazzolle MF, de Carvalho LM, Slepicka
HH, Vidal RO, Pereira GA, Kobarg J and Meirelles GV: IIS-Integrated
interactome system: A web-based platform for the annotation,
analyses and visualization of protein-metabolite-gene-drug
interactions by integrating a variety of data sources and tools.
PLoS One. 9:e1003852014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Streckfus CF, Mayorga-Wark O, Arreola D,
Edwards C, Bigler L and Dubinsky WP: Breast cancer related proteins
are present in saliva and are modulated secondary to ductal
carcinoma in situ of the breast. Cancer Invest. 26:159–167. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Streckfus CF, Arreola D, Edwards C and
Bigler L: Salivary protein profiles among
HER2/neu-receptor-positive and -negative breast cancer patients:
Support for using salivary protein profiles for modeling breast
cancer progression. J Oncol. 2012:4132562012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Streckfus CF, Storthz KA, Bigler L and
Dubinsky WP: A comparison of the proteomic expression in pooled
saliva specimens from individuals diagnosed with ductal carcinoma
of the breast with and without lymph node involvement. J Oncol.
2009:7376192009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Liang Y, Wang Y, Cui J, Liu M, Du
W and Xu Y: Computational prediction of human salivary proteins
from blood circulation and application to diagnostic biomarker
identification. PLoS One. 8:e802112013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Y, Rhodus NL, Ondrey FG, Wuertz BR,
Chen X, Zhu Y and Griffin TJ: Quantitative proteomic analysis of
oral brush biopsies identifies secretory leukocyte protease
inhibitor as a promising, mechanism-based oral cancer biomarker.
PLoS One. 9:e953892014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jehmlich N, Stegmaier P, Golatowski C,
Salazar MG, Rischke C, Henke M and Völker U: Differences in the
whole saliva baseline proteome profile associated with development
of oral mucositis in headand neck cancer patients undergoing
radiotherapy. J Proteomics. 125:98–103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
daRosa MR, Falcão AS, Fuzii HT, da Silva
Kataoka MS, Ribeiro AL, Boccardo E, de Siqueira AS, Jaeger RG, de
Jesus Viana Pinheiro J and de Melo Alves Júnior S: EGFR signaling
downstream of EGF regulates migration, invasion and MMP secretion
of immortalized cells derived from human ameloblastoma. Tumour
Biol. 35:11107–11120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang F and Chen JY: Breast cancer
subtyping from plasma proteins. BMC Med Genomics. 6(Supply 1):
S62013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bandow JE: Comparison of protein
enrichment strategies for proteome analysis of plasma. Proteomics.
10:1416–1425. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Timms JF, Arslan-Low E, Gentry-Maharaj A,
Luo Z, T'Jampens D, Podust VN, Ford J, Fung ET, Gammerman A, Jacobs
I and Menon U: Preanalytic influence of sample handling on
SELDI-TOF serum protein profiles. Clin Chem. 53:645–656. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van Winden AW, van den Broek I, Gast MC,
Engwegen JY, Sparidans RW, van Dulken EJ, Depla AC, Cats A,
Schellens JH, Peeters PH, et al: Serum degradome markers for the
detection of breast cancer. J Proteome Res. 9:3781–3788. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Opstal-van Winden AW, Krop EJ, Kåredal MH,
Gast MC, Lindh CH, Jeppsson MC, Jönsson BA, Grobbee DE, Peeters PH,
Beijnen JH, et al: Searching for early breast cancer biomarkers by
serum protein profiling of pre-diagnostic serum; A nested
case-control study. BMC Cancer. 11:3812011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mazouni C, Baggerly K, Hawke D,
Tsavachidis S, André F, Buzdar AU, Martin PM, Kobayashi R and
Pusztai L: Evaluation of changes in serum protein profiles during
neoadjuvant chemotherapy in HER2-positive breast cancer using an
LC-MALDI-TOF/MS procedure. Proteomics. 10:3525–3532. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang J, Eliassen AH, Spiegelman D, Willett
WC and Hankinson SE: Plasma free 25-hydroxyvitamin D, vitamin D
binding protein and risk of breast cancer in the Nurses' Health
Study II. Cancer Causes Control. 25:819–827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mondul AM, Weinstein SJ, Virtamo J and
Albanes D: Influence of vitamin D binding protein on the
association between circulating vitamin D and risk of bladder
cancer. Br J Cancer. 107:1589–1594. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weinstein SJ, Stolzenberg-Solomon RZ, Kopp
W, Rager H, Virtamo J and Albanes D: Impact of circulating vitamin
D binding protein levels on the association between
25-hydroxyvitamin D and pancreatic cancer risk: A nested
case-control study. Cancer Res. 72:1190–1198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Weinstein SJ, Mondul AM, Kopp W, Rager H,
Virtamo J and Albanes D: Circulating 25-hydroxyvitamin D, vitamin
D-binding protein and risk of prostate cancer. Int J Cancer.
132:2940–2947. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zinser G, Packman K and Welsh J: Vitamin D
(3) receptor ablation alters mammary gland morphogenesis.
Development. 129:3067–3076. 2002.PubMed/NCBI
|
|
43
|
Lopes N, Paredes J, Costa JL, Ylstra B and
Schmitt F: Vitamin D and the mammary gland: A review on its role in
normal development and breast cancer. Breast Cancer Res.
14:2112012. View Article : Google Scholar : PubMed/NCBI
|
